Product Images Jevtana

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Jevtana NDC 0024-5824 by Sanofi-aventis U.s. Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - jevtana 01

Chemical Structure - jevtana 01

Figure 1 - jevtana 02

Figure 1 - jevtana 02

Figure 2 - jevtana 03

Figure 2 - jevtana 03

PRINCIPAL DISPLAY PANEL - Kit Carton - jevtana 04

PRINCIPAL DISPLAY PANEL - Kit Carton - jevtana 04

The text is describing a graph that shows the rPFS (months) using Kaplan-Meier curves, based on an ITT population that was treated with Cabazitaxel + Censored or Enzalutamide/Abiraterone. The graph shows the number at risk over time, which is displayed in months. There are no additional details available.*

PRINCIPAL DISPLAY PANEL - 60 mg/1.5 mL Vial Label - jevtana 05

PRINCIPAL DISPLAY PANEL - 60 mg/1.5 mL Vial Label - jevtana 05

This is information related to the drug JEVTANA which is used for intravenous infusion only after proper dilution. It is a cytotoxic agent and its dosage is provided. The package contains two vials, one with the actual drug and the other with the diluent. The text also includes warnings and the components of the drug.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.